Form 4 for RMD ResMed|
Accepted 2023-05-12 00:00:00 ET · period of report 2023-05-10 · accession 0001127602-23-015482 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-12 | 2023-05-10 | RMD | Sandercock Brett | CFO | S - Sale | $233.13 | -12.6K | 90.9K | -12% | -$2.93M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-05-10 | S | D | 12,574 | $233.13 | 90,942 | D | — | — |